Concepedia

Michael D. Arensman

MD

5

Publications

418

Citations

5

H-Index

2012

Active since

Affiliations

University of California, Los Angeles(Current)

Pfizer (United States)

Michael D. Arensman is an author at University of California, Los Angeles specializing in cancer biology, medicine, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyCancer ResearchRadiation OncologyOncologyImmunologyImmunotherapyCell Signaling

Publications per year

2012–2020

5

Publications

5

Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity

Michael D. Arensman, Xiaoran Yang, Danielle Leahy et al. · Proceedings of the National Academy of Sciences · 2019 · 163 citations · Full text

Chemoprevention Strategy, Immunology, Antitumor Immunity +19

The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth

Michael D. Arensman, Donatello Telesca, Anna R. Lay et al. · Molecular Cancer Therapeutics · 2014 · 116 citations · Full text

Tumor Biology, Signaling Pathway, Pdac Apoptosis +12

HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma

Anne Kovochich, Michael D. Arensman, Anna R. Lay et al. · Cancer · 2012 · 64 citations · Full text

Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer

Michael D. Arensman, Phillip Nguyen, Kathleen M. Kershaw et al. · Molecular Cancer Research · 2015 · 51 citations · Full text

Anti-tumor immunity influences cancer cell reliance upon ATG7

Michael D. Arensman, Xiaoran Yang, Wenyan Zhong et al. · OncoImmunology · 2020 · 24 citations · Full text

Rows per page

1–5 of 5